Literature DB >> 11061960

Influence of left atrial enlargement and body weight on the development of atrial fibrillation: retrospective study on 205 dogs.

C Guglielmini1, V Chetboul, M Pietra, J L Pouchelon, A Capucci, M Cipone.   

Abstract

We studied 205 dogs with cardiac diseases associated with left atrial enlargement (LAE). On the basis of electrocardiogram results, they were divided into: Group A, 50 dogs with atrial fibrillation (AF) and Group B, 155 dogs without AF. Group B was further subdivided in Group BI (123 dogs with sinus rhythm) and Group BII (32 dogs with cardiac arrhythmias other than AF). Bodyweight (BW) and left atrial diameter (LA) of Group A dogs were significantly greater (P< 0.05) than dogs in all other groups. The left atrium/aorta (LA/Ao) ratio of Group A dogs was significantly higher (P< 0.05) than that of dogs of Group B and BI. Using the couple of variables BW and LA, the logistic regression models were able to predict "non-development of AF" (with 92.3% probability) vs. "development of AF" (with 74% probability), and "maintaining sinus rhythm" (with 95.1% probability) vs."development of AF" (with 86% probability). Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 11061960     DOI: 10.1053/tvjl.2000.0506

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  8 in total

1.  Paroxysmal atrial fibrillation in a dog that was presented for neck wounds.

Authors:  Samuel J Hornsey; Anthony P Carr; Jennifer M Loewen
Journal:  Can Vet J       Date:  2021-01       Impact factor: 1.008

2.  Serum digoxin concentrations in dogs with atrial fibrillation under long term digoxin treatment.

Authors:  Antonella Colella; Serena Digiaro; Marco Fiorentino; Beatrice Greco; Mariateresa Sasanelli; Paola Paradies
Journal:  Open Vet J       Date:  2022-06-03

3.  Serum Total Antioxidant Capacity and Enzymatic Defence of Dogs with Chronic Heart Failure and Atrial Fibrillation: A Preliminary Study.

Authors:  Marcin Michałek; Aleksandra Tabiś; Agnieszka Noszczyk-Nowak
Journal:  J Vet Res       Date:  2020-07-28       Impact factor: 1.744

4.  Dronedarone attenuates the duration of atrial fibrillation in a dog model of sustained atrial fibrillation.

Authors:  Nakkawee Saengklub; Vudhiporn Limprasutr; Suwanakiet Sawangkoon; Robert L Hamlin; Anusak Kijtawornrat
Journal:  Exp Anim       Date:  2017-04-04

5.  Prevalence and risk factors for atrial fibrillation in dogs with myxomatous mitral valve disease.

Authors:  Carlo Guglielmini; Marlos Goncalves Sousa; Marco Baron Toaldo; Carlotta Valente; Vinicius Bentivoglio; Chiara Mazzoldi; Ilaria Bergamin; Michele Drigo; Helen Poser
Journal:  J Vet Intern Med       Date:  2020-10-08       Impact factor: 3.333

6.  Acute effects of intravenous dronedarone on electrocardiograms, hemodynamics and cardiac functions in anesthetized dogs.

Authors:  Nakkawee Saengklub; Vudhiporn Limprasutr; Suwanakiet Sawangkoon; Chollada Buranakarl; Robert L Hamlin; Anusak Kijtawornrat
Journal:  J Vet Med Sci       Date:  2015-09-04       Impact factor: 1.267

7.  Efficacy of pentamidine analogue 6 in dogs with chronic atrial fibrillation.

Authors:  Viktor Szatmári; Yuan Ji; Bianca van Herwijnen; Mei Feng; Michael Zhou Wang; Alexandre Bossu; Marcel A G van der Heyden
Journal:  J Vet Intern Med       Date:  2018-08-05       Impact factor: 3.333

8.  Echocardiographic predictors of first onset of atrial fibrillation in dogs with myxomatous mitral valve disease.

Authors:  Marco Baron Toaldo; Chiara Mazzoldi; Giovanni Romito; Helen Poser; Barbara Contiero; Mario Cipone; Carlo Guglielmini
Journal:  J Vet Intern Med       Date:  2020-08-07       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.